Key result
This review discusses critical unanswered questions in the management of venous thromboembolism, which affects at least 250,000 new patients annually in the United States.
This review highlights critical unanswered questions regarding the management and duration of anticoagulation therapy for venous thromboembolism.
No takes yet. Share an insight, caveat, or question.
Uncertainties in VTE anticoagulation duration persist; leaves open optimal strategies for clinicians and future trials.
Key et al. (2010) conducted a review in Venous thromboembolism. Anticoagulation was evaluated. This review discusses critical unanswered questions in the management of venous thromboembolism, which affects at least 250,000 new patients annually in the United States.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: